Senate Passes Insulin Cap Bill

Last Tuesday, on March 25th, the North Dakota Senate voted 39-7 to pass a bill that would cap insulin at $25. House Bill 1114 specifically limits out-of-pocket costs for monthly supplies of insulin at $25 for North Dakota’s commercial insurance market. The bill also provides a $25-a-month cap on insulin-related medical supplies. These caps affect people on individual, small group, and large group insurance plans in the fully insured market. This doesn’t apply to the self-insured market. 

For further elaboration on what this bill means, I’ve explained some of the key terms and factors. For people paying out-of-pocket, meaning the payment is covered completely by the individual without help from insurance, the cap will reduce the costs of Insulin even despite a previous cap of $35. As previously mentioned, the cap doesn’t apply to self-insurance, meaning people who set aside emergency funds instead of paying insurance, but these out-of-pocket caps could help some individuals who are also self-insured.